相关实验视频
Updated: Sep 13, 2025

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
532
通过METTL14介导的m6A甲基化稳定OTUD7B驱动HIF-1α表达在食道状细胞癌中的表达
Fei Ren1, Yansen Cai2, Yang Song1
1Laboratory Animal Centre, Changzhi Medical College, Changzhi, 046000, China.
Oncology research
|August 1, 2025
概括
卵巢瘤二基因酶7B (OTUD7B) 通过通过N6-甲基氨酸 (m6A) 甲基化稳定缺氧诱导因子-1α (HIF-1α),在食道状细胞癌 (ESCC) 中起到瘤基因作用. 针对METTL14-OTUD7B途径为ESCC提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 表观遗传修饰,特别是N6-甲基氨酸 (m6A) 甲基化,越来越多地被认为是它们在癌症发展中的作用.
- 卵巢瘤二维基因酶7B (OTUD7B) 涉及到各种细胞过程,但其在食道状细胞癌 (ESCC) 中在m6A和缺氧信号的背景下发挥的特定作用仍未得到充分研究.
研究的目的:
- 调查OTUD7B在ESCC中的作用.
- 阐明OTUD7B,m6A甲基化和ESCC中缺氧诱导因子-1α (HIF-1α) 途径之间的关系.
主要方法:
- 使用GSE179267数据集进行差异基因表达分析.
- 对TCGA,CCLE和SRAMP数据库进行生物信息分析,以评估OTUD7B表达及其与METTL14和HIF-1α的相关性.
- 点点和基因特异的m6A-PCR来量化OTUD7BmRNA中的m6A修饰.
- 克隆基因和Transwell测试来评估OTUD7B的功能作用.
- 同免疫沉试验检测OTUD7B对HIF-1α无化发生的影响.
主要成果:
- 在ESCC中,OTUD7B被确定为m6A驱动的瘤基因,与METTL14和HIF-1α正相关.
- 发现METTL14通过m6A甲基化增强OTUD7BmRNA的稳定性和表达.
- OTUD7B过度表达挽救了METTL14对细胞增殖和侵入的抑制作用.
- OTUD7B通过促进其二氧化化,稳定了HIF-1α.
结论:
- 通过METTL14介导的m6A甲基化稳定了OTUD7B,这反过来又抑制了ESCC中HIF-1α的无素-蛋白质体降解.
- METTL14-OTUD7B轴代表了ESCC治疗的潜在治疗目标.
相关概念视频
Master Transcription Regulators
7.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.1K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Covalently Linked Protein Regulators
7.2K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.2K

